(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium

C16H15N4OSY- — CID 58223196

IUPAC(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium
SMILESCc1cn(-c2ccc(/C=C3\[N-]C(=S)N(C)C3=O)cc2C)cn1.[Y]
InChIInChI=1S/C16H16N4OS.Y/c1-10-6-12(7-13-15(21)19(3)16(22)18-13)4-5-14(10)20-8-11(2)17-9-20;/h4-9H,1-3H3,(H,18,22);/p-1/b13-7-;
InChIKeySEQSYTRTBMZCQJ-QCCGTXRUSA-M
MW400.30 g/mol
LogP2.96
Rot. Bonds2

About (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium

(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium (PubChem CID 58223196) has the molecular formula C16H15N4OSY- and a molecular weight of 400.30 g/mol. Its IUPAC name is (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium.

Molecular Properties

Compound Name(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium
PubChem CID58223196
Molecular FormulaC16H15N4OSY-
Molecular Weight400.30 g/mol
Exact Mass400.00
IUPAC Name(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium
SMILESCc1cn(-c2ccc(/C=C3\[N-]C(=S)N(C)C3=O)cc2C)cn1.[Y]
InChIInChI=1S/C16H16N4OS.Y/c1-10-6-12(7-13-15(21)19(3)16(22)18-13)4-5-14(10)20-8-11(2)17-9-20;/h4-9H,1-3H3,(H,18,22);/p-1/b13-7-;
InChIKeySEQSYTRTBMZCQJ-QCCGTXRUSA-M
XLogP2.96
TPSA52.23 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms23
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500400.30
LogP ≤ 52.96
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium?
The IUPAC name of (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium (CID 58223196) is (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium.
What is the SMILES notation for (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium?
The canonical SMILES for (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium is Cc1cn(-c2ccc(/C=C3\[N-]C(=S)N(C)C3=O)cc2C)cn1.[Y].
What is the InChIKey of (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium?
The InChIKey is SEQSYTRTBMZCQJ-QCCGTXRUSA-M. The full InChI is InChI=1S/C16H16N4OS.Y/c1-10-6-12(7-13-15(21)19(3)16(22)18-13)4-5-14(10)20-8-11(2)17-9-20;/h4-9H,1-3H3,(H,18,22);/p-1/b13-7-;.
What are the key properties of (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium?
(5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium has a molecular weight of 400.30 g/mol, XLogP of 2.96, 2 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (5Z)-3-methyl-5-[[3-methyl-4-(4-methylimidazol-1-yl)phenyl]methylidene]-2-sulfanylideneimidazolidin-1-id-4-one;yttrium is sourced from PubChem (CID 58223196), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).